Determining Minimal Residual Disease Using ctDNA Deep Sequencing

Clinical trial NCT07660627 · RECRUITING

Trial details

NCT number: NCT07660627
Sponsor: Masaryk Memorial Cancer Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Esophageal Adenocarcinoma Gastric Cancer Pancreatic Cancer

Start date: 2022-08-22
Primary completion: 2026-12-31
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.